SELL MRNA · 1 Day pick · Oct 23, 2026
+33% vs analyst target · new source · 2 agree · 1 dissent
Why SELL: Our read: the melanoma-vaccine 'sell the news' selloff (-18% Thursday, ~$24B lost) is still running, -4% more premarket.
⚠ Analysts call the 42% risk cut 'solid' and 'exceptional'; full data hits ESMO Saturday and Brookline now targets $250.
MRNA was $194.50 when we published the SELL call on Oct 23. It's now $202.63, -4.18% for the SELL side.
Source: Yahoo Finance prices, updated Oct 23, 7:09 AM ET.
The Daily Five's 1 Day call from Oct 23 is SELL MRNA at $194.50. Why: Our read: the melanoma-vaccine 'sell the news' selloff (-18% Thursday, ~$24B lost) is still running, -4% more premarket. Not financial advice.
MRNA was $194.50 when we published the SELL call on Oct 23. It's now $202.63, -4.18% for the SELL side.
Our top-scored value pick for NBA: POR @ SAC is priced under the sportsbooks. The side is in the email.